Vincent K Blair Insurance Blog

The FDA is considering revoking its approval of the drug Avastin for use on women with advanced breast cancer.  True, the drug may only extend life by a few months but the precedent is disturbing, as this article from a British newspaper points out. Will the FDA become the 'death panel' detractors of the healthcare law warned us about?

Comments (0) | Trackbacks (0) | Permalink